Form 8-K - Current report:
SEC Accession No. 0001193125-17-206137
Filing Date
2017-06-16
Accepted
2017-06-16 17:28:33
Documents
1
Period of Report
2017-06-15
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 5.07: Submission of Matters to a Vote of Security Holders
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d412586d8k.htm 8-K 33132
  Complete submission text file 0001193125-17-206137.txt   34479
Mailing Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080
Business Address 260 LITTLEFIELD AVENUE SOUTH SAN FRANCISCO CA 94080 6507450655
CATALYST BIOSCIENCES, INC. (Filer) CIK: 0001124105 (see all company filings)

EIN.: 562020050 | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-51173 | Film No.: 17916973
SIC: 2834 Pharmaceutical Preparations